Last €42.28 EUR
Change Today -0.60 / -1.40%
Volume 44.0
8FM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:28 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin Krenitsky M.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

47--

Background*

Dr. Kevin Krenitsky, M.D., has been Advisor of Foundation Medicine, Inc. since December 2014. Dr. Krenitsky served as the Chief Commercial Officer and Senior Vice President of International Strategy of Foundation Medicine, Inc. until December 2014 and served as its Chief Operating Officer since June 16, 2011. Dr. Krenitsky leads Foundation Medicine's internal operations and commercialization plans for its comprehensive cancer diagnostic test. He has 15 years of experience ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
Thomas Jefferson University
BS
University of Scranton

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8FM:GR €42.28 EUR -0.60

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.